Option chain shows key data for NovaBay Pharmaceuticals's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for NovaBay Pharmaceuticals.

NovaBay Pharmaceuticals (AMEX:NBY) Stock, Option Chain

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.

Medicine

News

Movers

NovaBay shares are trading higher after the company announced it reached a definitive agreement to sell its Avenova assets for $9.5 million to Physician Recommended Nutraceuticals.

What&#39;s Going On With NovaBay Pharmaceuticals Shares Friday?

vaccine-4892048

NovaBay Pharmaceuticals shares are lower by 66% over the trailing five sessions. The company last week announced the pricing of its public offering.

What&#39;s Going On With NovaBay Pharmaceuticals (NBY) Stock?

Earnings

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

COUR

DXCM

NMHI

WINT

S&amp;P 500 Gains Over 1%; 3M Shares Jump After Q2 Results

NovaBay Pharmaceuticals, Inc. Common Stock

NovaBay Pharmaceuticals Inc

Niobay Metals Inc

Press Releases

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTTR, NBY, ARC on Behalf of Shareholders

NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC

NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price

NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results

Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand

NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024

NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders

NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal

NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders

BTTR

Adial Pharmaceuticals, Inc - Common Stock

Adial Pharmaceuticals

Akanda

Artelo Biosciences

Avenue Therapeutics

CNS Pharma

China Pharma Holding

Enveric Biosciences

Evoke Pharma

Eyenovia

Hepion Pharmaceuticals, Inc. - Common Stock

Hepion Pharmaceuticals

Processa Pharmaceuticals, Inc. - Common Stock

Processa Pharma

Petros Pharmaceuticals, Inc. - Common Stock

Petros Pharma

Redhill Biopharma Ltd. - American Depositary Shares

Redhill Biopharma

SenesTech

Sonoma Pharmaceuticals, Inc. - Common Stock

Sonoma Pharmaceuticals

China SXT Pharmaceuticals, Inc. - Common Stock

China SXT Pharmaceuticals

60 Degrees Pharmaceuticals, Inc. - Common Stock

60 Degrees

TNF Pharmaceuticals

Titan Pharmaceuticals, Inc. - Common Stock

Titan Pharma

Universe Pharmaceuticals Inc - Ordinary Shares

Universe Pharmaceuticals

Virpax Pharmaceuticals, Inc. - Common Stock

Comments

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals (NBY) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga